Literature DB >> 23379968

Urban legends series: oral leukoplakia.

P G Arduino1, J Bagan, A K El-Naggar, M Carrozzo.   

Abstract

To date, the term oral leukoplakia (OL) should be used to recognize 'predominantly white plaques of questionable risk, having excluded (other) known diseases or disorders that carry no increased risk of cancer'. In this review, we addressed four controversial topics regarding oral leukoplakias (OLs): (i) Do tobacco and alcohol cause OLs?, (ii) What percentage of OLs transform into oral squamous cell carcinoma (OSCC)?, (iii) Can we distinguish between premalignant and innocent OLs?, and (iv) Is proliferative verrucous leukoplakia (PVL) a specific entity or just a form of multifocal leukoplakia? Results of extensive literature search suggest that (i) no definitive evidence for direct causal relationship between smoked tobacco and alcohol as causative factors of OLs, (ii and iii) the vast majority of OLs follow a benign course and do not progress into a cancer, and no widely accepted and/or validated clinical and/or biological factors can predict malignant transformation, and (iv) the distinction between multifocal/multiple leukoplakias and PVL in their early presentation is impossible; the temporal clinical progression and the high rate of recurrences and development of cancer of PVL are the most reliable features for diagnosis.
© 2012 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  head and neck; hyperkeratosis; premalignancy; squamous carcinoma; squamous epithelium

Mesh:

Year:  2013        PMID: 23379968     DOI: 10.1111/odi.12065

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  24 in total

1.  Idiopathic leukoplakia- report of a rare case and review.

Authors:  Shesha Prasad R; Ramakrishna T; Anuradha Pai; Sujatha D
Journal:  J Clin Diagn Res       Date:  2015-03-01

Review 2.  Oral Epithelial Dysplasia and Premalignancy.

Authors:  Sook-Bin Woo
Journal:  Head Neck Pathol       Date:  2019-03-18

3.  Effectiveness of mouth self-examination for screening of oral premalignant/malignant diseases in tribal population of Dehradun district.

Authors:  Amit Shah; Bharat Bhushan; Saifullah Akhtar; Pankaj Kumar Singh; Madhur Garg; Mayank Gupta
Journal:  J Family Med Prim Care       Date:  2020-08-25

Review 4.  Clinical assessment for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults.

Authors:  Tanya Walsh; Saman Warnakulasuriya; Mark W Lingen; Alexander R Kerr; Graham R Ogden; Anne-Marie Glenny; Richard Macey
Journal:  Cochrane Database Syst Rev       Date:  2021-12-10

Review 5.  Dietary Carotenoids in Head and Neck Cancer-Molecular and Clinical Implications.

Authors:  Katarzyna Starska-Kowarska
Journal:  Nutrients       Date:  2022-01-26       Impact factor: 5.717

6.  Oral leukoplakia in the Sudan: clinicopathological features and risk factors.

Authors:  Mayson B Mustafa; Mohammed O Hassan; Abdelazeem Alhussein; Eltahir Mamoun; Mariam El Sheikh; Ahmed M Suleiman
Journal:  Int Dent J       Date:  2019-08-12       Impact factor: 2.607

7.  Architectural Alterations in Oral Epithelial Dysplasia are Similar in Unifocal and Proliferative Leukoplakia.

Authors:  Chia-Cheng Li; Soulafa Almazrooa; Ingrid Carvo; Alfonso Salcines; Sook-Bin Woo
Journal:  Head Neck Pathol       Date:  2020-09-16

8.  Recurrence in Oral Premalignancy: Clinicopathologic and Immunohistochemical Analysis.

Authors:  Maria Georgaki; Dimitris Avgoustidis; Vasileios Ionas Theofilou; Evangelia Piperi; Efstathios Pettas; Demos G Kalyvas; Dimitrios Vlachodimitropoulos; Christos Perisanidis; Andreas C Lazaris; Nikolaos G Nikitakis
Journal:  Diagnostics (Basel)       Date:  2021-05-12

9.  Expression of β-catenin in oral leukoplakia and oral submucous fibrosis: An immunohistochemical study.

Authors:  Pritha Chowdhury; B R Nagamalini; Jaya Singh; B K Ashwini; Uma Swaminathan
Journal:  J Oral Maxillofac Pathol       Date:  2021-05-14

10.  Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions.

Authors:  Tanya Walsh; Richard Macey; Alexander R Kerr; Mark W Lingen; Graham R Ogden; Saman Warnakulasuriya
Journal:  Cochrane Database Syst Rev       Date:  2021-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.